Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice

Tundra lists 1 Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07508007

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings

Lipoprotein(a) \[Lp(a)\] is recognised as an independent, non-modifiable genetic risk factor for cardiovascular (CV) disease. Current guidelines from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) recommend that Lp(a) be measured at least once in every adult's lifetime, however routine Lp(a) testing rates remains infrequent. The aim of this study is to assess the impact of implementation strategies (IStr) designed to increase the adoption of Lp(a) testing in routine practice, ultimately leading to more individuals being tested in secondary care. This, in turn, is expected to result in the identification and enhanced management of Cardiovascular Disease (CVD) risk patients with elevated Lp(a).

Gender: All

Ages: 18 Years - Any

Updated: 2026-04-02

Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice